Women who have mutations in BRCA1 and BRCA2 genes are at a high risk of developing breast cancer, with an estimated annual risk of 2%–3% and a lifetime risk of approximately 70% (23); furthermore, bilateral prophylactic mastectomies remain the most effective approach for reducing breast cancer risk (24). The gene discussed is BRCA2; the disease is breast carcinoma.